Puma Biotechnology Inc (PBYI)
4.17
-0.20
(-4.58%)
USD |
NASDAQ |
May 21, 16:00
4.175
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Accounts Receivable (Quarterly): 24.58M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 24.58M |
| December 31, 2023 | 47.84M |
| September 30, 2023 | 28.97M |
| June 30, 2023 | 31.29M |
| March 31, 2023 | 31.16M |
| December 31, 2022 | 40.35M |
| September 30, 2022 | 28.03M |
| June 30, 2022 | 33.99M |
| March 31, 2022 | 27.04M |
| December 31, 2021 | 32.53M |
| September 30, 2021 | 23.80M |
| June 30, 2021 | 30.55M |
| March 31, 2021 | 26.16M |
| December 31, 2020 | 25.54M |
| September 30, 2020 | 27.14M |
| June 30, 2020 | 23.99M |
| Date | Value |
|---|---|
| March 31, 2020 | 31.54M |
| December 31, 2019 | 28.90M |
| September 30, 2019 | 27.18M |
| June 30, 2019 | 25.35M |
| March 31, 2019 | 80.98M |
| December 31, 2018 | 20.77M |
| September 30, 2018 | 19.75M |
| June 30, 2018 | 21.34M |
| March 31, 2018 | 16.31M |
| December 31, 2017 | 9.67M |
| September 30, 2017 | 3.89M |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 1.179M |
| June 30, 2016 | 1.179M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
23.80M
Minimum
Sep 2021
47.84M
Maximum
Dec 2023
29.80M
Average
28.46M
Median
Accounts Receivable (Quarterly) Benchmarks
| ADMA Biologics Inc | 49.62M |
| Pfizer Inc | 10.99B |
| United Therapeutics Corp | 307.30M |
| Vanda Pharmaceuticals Inc | 36.71M |
| Sarepta Therapeutics Inc | 378.81M |